Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma. - Wikidata - wikimedia - TriplyDB

Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma.

Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma.

http://www.wikidata.org/entity/Q38051323

about

Overview of current immunotherapeutic strategies for glioma The progress of immunotherapy for glioblastoma Molecular heterogeneity in glioblastoma: potential clinical implications Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.Recent advances and future of immunotherapy for glioblastoma.Tumor lysate-loaded biodegradable microparticles as cancer vaccines.Liquid biopsies in patients with diffuse glioma.Toward precision medicine in glioblastoma: the promise and the challenges.Glioblastoma targeted therapy: updated approaches from recent biological insights.Prospect of rindopepimut in the treatment of glioblastoma.Novel vaccines for glioblastoma: clinical update and perspective.Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach.CNS cancer immunity cycle and strategies to target this for glioblastoma.Glioblastoma Treatments: An Account of Recent Industrial Developments

P2860

Q26776345-15CB6C88-FEBD-4D11-8CCF-EA5DB37B0A5B Q26797282-3FBF1AA9-D447-468F-94A5-A9F7DBFE8092 Q28088605-A870AC79-FF2E-417C-9490-E330AC879F07 Q33746514-F7AAD169-123F-4B93-A777-A9BE0CBE2551 Q34402325-4F4B1D24-2296-4B66-8FC1-43C51747BD32 Q34552791-3AD6BAA8-E2EB-4967-A203-A50554C1FB13 Q37239071-4B81E49B-3A7D-4CA2-AD84-690ECDF93917 Q37670779-49C1CE99-29A9-48D1-8760-EB333B3BB5C3 Q38365590-AC268404-91C8-4652-AD6A-5E74606DA94D Q38454659-9D19EC7A-5104-43E4-9307-A116A05443B1 Q38597700-45157BA2-5805-4048-B835-3D6C12A9EBB0 Q38748694-FC5E0764-6C3F-46A6-9E15-32E758B3A697 Q39043417-967A3608-3395-4C3F-87D1-EE3A6D4758EC Q39829133-A58DE27E-452B-4286-82D2-62858B192F51 Q52365121-50DB44D7-21A7-49EB-9BE4-7163F9629241 Q55259532-38F97139-04DA-452A-B00A-DE9F33065F78 Q57111067-36C98F15-C8E1-4B1C-9607-0BAB01AABE75

P2860

Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma.

http://www.wikidata.org/entity/Q38051323

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Rindopepimut: an evidence-base ...... GFRvIII-positive glioblastoma.

@en

type

label

Rindopepimut: an evidence-base ...... GFRvIII-positive glioblastoma.

@en

prefLabel

Rindopepimut: an evidence-base ...... GFRvIII-positive glioblastoma.

@en

P1433

Q38051323-EFAC7199-6622-42D8-A326-CC4D1109CE98

P1476

Q38051323-A046452F-EE77-4FD1-811C-37A1039896ED

P2093

Q38051323-4B20EB25-62DB-472A-8A82-D53826659DF0

Q38051323-6783B45D-4940-4841-9D04-ADE913031942

P2860

Q38051323-01D80DC1-70C4-441A-8219-39F4285863C6

Q38051323-05251759-1111-4CBA-AEB8-20A991130572

Q38051323-0B86BB75-CDD4-4B99-97FC-3D34B617C03E

Q38051323-1086E964-6356-4638-A6D1-EDF1ADEAE824

Q38051323-18EBD2E6-1B50-4043-BB75-5787B756B3AA

Q38051323-1A7CE454-C9C2-43CB-866C-0A55310BC7F3

Q38051323-1AE92C0A-51BD-47DA-8DF7-AAC0754D54DB

Q38051323-1BF0E51F-91EC-4A7F-867E-EDC90FE59C9C

Q38051323-1C140B5C-D3D0-4763-A057-E38FDCA90836

Q38051323-1D205CBF-95AA-4784-B3A9-1E65C521B9B9

P304

Q38051323-B5721D17-4D51-4A4D-84BE-6976B36D9180

P31

Q38051323-C0DA0463-682D-479E-BD0A-9A425A2D05B4

P356

Q38051323-61A50A24-6580-419D-8381-CBCFCC569B50

P407

Q38051323-8DF63B46-C951-4A3B-99CB-803860914902

P478

Q38051323-0EB181D8-C486-4904-857D-9BFFAA086B90

P577

Q38051323-2CC543BD-6634-440F-9C4E-34EB16C28FB8

P698

Q38051323-3B3522E7-CF8B-4344-B021-C9CC8C419D95

P932

Q38051323-C5627864-A853-48B1-A00C-BCC65E622778

P356

P1433

P1476

Rindopepimut: an evidence-base ...... GFRvIII-positive glioblastoma.

@en

P2093

D Cory Adamson

http://www.w3.org/2001/XMLSchema#string

Ranjith Babu

http://www.w3.org/2001/XMLSchema#string

P2860

CNS immune privilege: hiding in plain sight.

IDH1 and IDH2 mutations in gliomas

The natural history of EGFR and EGFRvIII in glioblastoma patients

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

Development of an EGFRvIII specific recombinant antibody

P304

93-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CE.S29001

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23055947

http://www.w3.org/2001/XMLSchema#string

P932

3459544

http://www.w3.org/2001/XMLSchema#string